Shock Pathogenesis and Therapy 1962
DOI: 10.1007/978-3-662-22403-8_30
|View full text |Cite
|
Sign up to set email alerts
|

Drug therapy of shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
24
0

Year Published

1965
1965
1998
1998

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 34 publications
0
24
0
Order By: Relevance
“…
In several species, including man, the continuous infusion of noradrenaline always results in an eventual steady decline from the initial pressor level (Nickerson, 1962;Rosenthale & Dipalma, 1963;Beyth & Gutman, 1965). This reduction in response is usually attributed to desensitization or tachyphylaxis.
…”
mentioning
confidence: 99%
“…
In several species, including man, the continuous infusion of noradrenaline always results in an eventual steady decline from the initial pressor level (Nickerson, 1962;Rosenthale & Dipalma, 1963;Beyth & Gutman, 1965). This reduction in response is usually attributed to desensitization or tachyphylaxis.
…”
mentioning
confidence: 99%
“…Using rat pleural polymorphonuclear leukocytes as a model , we found that inhibition of arachidonic acid metabolism was observed only when atropine, anisodamine and scopolamine were used at millimolar concentrations and the incubation period was extended to 30 min (unpublished data). In comparison, aladrenoceptor blockade was exerted by micromolar concentrations ofanisodamine, which can be clinically achieved and, like other adrenoceptor antagonists (Nickerson, 1962), be effective in maintaining the competence of microcirculation. On the other hand, anisodine is far too weak as an adrenoceptor antagonist for it to be likely that this property makes an important contribution to its clinical usefulness in shock.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, atropine-like agents have long been known to possess adrenergic antagonistic properties (Bussell, 1940;Burn & Dutta, 1948;Fleckenstein, 1952;Furchgott, 1955); recent studies have confirmed these observations and characterized these agents as specific xl-adrenoceptor antagonists (Abraham et al, 1981;Cantor et al, 1983). a-Adrenoceptor antagonism can be beneficial in circulatory shock (Nickerson, 1962). However, whether or not anisodamine and anisodine possess adrenergic inhibiting activities is not known.…”
Section: Introductionmentioning
confidence: 99%
“…Significant increases in the survival rate of animals subjected to various types of shock have been demonstrated and discussed using many different drugs and procedures to induce vasodilation (12). For example, dibenzyline, which is an adrenergic blocking agant, was found to prevent death of animals in a state of shock.…”
Section: Discussionmentioning
confidence: 99%